aisoftware

Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS)

Research Papers / aisoftware

Kurome Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KME-0584 for the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) Read More »

Double trouble: IRAK1/4 inhibitors in AML/MDS

Research Papers / aisoftware

Double trouble: IRAK1/4 inhibitors in AML/MDS Read More »